Delivery Order SPE2DB20D9331-SPE2DB22FL1E8
Award Date 7/18/22
Potential Completion Date 8/8/22
Potential Value $7.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,002.84 order is for the delivery of PURIXAN 20 MG/ML oral suspension product. The order is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program. This single-award IDC enables the DLA to issue delivery orders...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,022.86, is for the delivery of Purixan 20 mg/ml oral suspension, a pharmaceutical product. The delivery order contract is part of a larger indefinite delivery vehicle (IDV) contract held by DMS Pharmaceutical Group with the DLA, valued at up to $4,999,999 through 2025. This IDV enables...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,091.44 contract is for the delivery of Purixan 20 mg/ml oral suspension in 100ml bottles, and has an ultimate completion date of October 1, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,258.24 contract is for the supply of PURIXAN 20 MG/ML ORAL SUSP 100ML, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which enables the agency to issue firm...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,061.84 contract is for the supply of PURIXAN 20 MG/ML ORAL SUSP 100ML, a pharmaceutical product. The delivery order has a completion date of July 30, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,022.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Purixan 20 mg/ml oral suspension in 100 ml containers, and has an ultimate completion date of December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued up to $3,852.56, is for the delivery of PURIXAN 20 MG/ML ORAL SUSP 100ML, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which allows the DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,045.74 order is for the supply of PURIXAN 20 MG/ML ORAL SUSP 100ML, a medication used to treat acute lymphoblastic leukemia. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, known as SPE2DB, which allows the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,045.74 firm fixed-price contract is for the supply of PURIXAN 20 MG/ML ORAL SUSP 100ML to DLA. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,331.04 order is for the supply of Purixan, a 20 mg/mL oral suspension medication, with a completion date of October 19, 2021. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999 and running through...